SCHEMBL14765009

SCHEMBL14765009

CCc1nc2ccccc2n2c(-c3ccc(OC)cc3)nnc12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 3/20 0.62
MAOB P27338 2/20 0.62
KDM4E B2RXH2 9/20 0.54
ALDH1A1 P00352 8/20 0.54
LMNA P02545 3/20 0.54
NPSR1 Q6W5P4 2/20 0.54
GAA P10253 2/20 0.54
TSHR P16473 2/20 0.54
SMN1; SMN2 Q16637 5/20 0.52
MAPT P10636 5/20 0.52
TP53 P04637 4/20 0.52
NPC1 O15118 1/20 0.52
RAB9A P51151 1/20 0.52
HTT P42858 5/20 0.51
L3MBTL1 Q9Y468 2/20 0.51
CNR2 P34972 1/20 0.51
HPGD P15428 4/20 0.50
HSD17B10 Q99714 2/20 0.50
PDE2A O00408 2/20 0.50
PDE10A Q9Y233 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14765203 0.85 MAOA (0.67) MAOAMAOBKDM4EALDH1A1LMNA
SCHEMBL14764975 0.75 MAOA (0.74) MAOAMAOBHPGDPDE2APDE10A
SCHEMBL10080422 0.72 KDM4E (0.80) KDM4EALDH1A1LMNANPSR1GAA
SCHEMBL30496676 0.70 KDM4E (1.00) KDM4EALDH1A1LMNANPSR1GAA
SCHEMBL14764776 0.70 TYMS (0.70) MAOAKDM4EALDH1A1HPGDHSD17B10
SCHEMBL5011775 0.70 ALDH1A1 (0.68) KDM4EALDH1A1LMNANPSR1GAA
SCHEMBL29056695 0.69 DRD3 (0.78) KDM4EALDH1A1LMNANPSR1GAA
SCHEMBL12325734 0.69 KDM4E (0.65) KDM4EALDH1A1LMNANPSR1GAA
SCHEMBL10847813 0.68 ALOX15 (0.60) MAOAMAOBKDM4EALDH1A1NPSR1
SCHEMBL6912346 0.68 ALDH1A1 (0.67) KDM4EALDH1A1LMNANPSR1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013034755-A1 TRIAZOLOPYRAZINE DERIVATIVES AND THEIR USE FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS H. LUNDBECK A/S (DK) 2013-03-14 WO claimed
WO-2013034755-A1 TRIAZOLOPYRAZINE DERIVATIVES AND THEIR USE FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS H. LUNDBECK A/S (DK) 2013-03-14 WO disclosed
WO-2013034755-A1 TRIAZOLOPYRAZINE DERIVATIVES AND THEIR USE FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS H. LUNDBECK A/S (DK) 2013-03-14 WO disclosed